BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 36789977)

  • 21.
    Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3278-3285. PubMed ID: 31379206
    [No Abstract]   [Full Text] [Related]  

  • 22. NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway.
    Ma P; Yu H; Zhu M; Liu L; Cheng L; Han Z; Jin W
    Cell Cycle; 2024 Mar; 23(5):588-601. PubMed ID: 38743408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA TFAP2A-AS1 plays an important role in oral squamous cell carcinoma: research includes bioinformatics analysis and experiments.
    Jie G; Peng S; Cui Z; He C; Feng X; Yang K
    BMC Oral Health; 2022 May; 22(1):160. PubMed ID: 35524329
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Huang C; Wang L; Song H; Wu C
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3037-3042. PubMed ID: 31342798
    [No Abstract]   [Full Text] [Related]  

  • 25. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway.
    Huang G; Chen S; Washio J; Paka Lubamba G; Takahashi N; Li C
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
    Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
    J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
    Xiong L; Tang Y; Tang J; Liu Z; Wang X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
    [No Abstract]   [Full Text] [Related]  

  • 29. KDM5B promotes metastasis and epithelial-mesenchymal transition via Wnt/β-catenin pathway in squamous cell carcinoma of the head and neck.
    Yuan W; Hu J; Wang M; Li G; Lu S; Qiu Y; Liu C; Liu Y
    Mol Carcinog; 2024 May; 63(5):885-896. PubMed ID: 38353298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-92a inhibits proliferation and promotes apoptosis of OSCC cells through Wnt/β-catenin signaling pathway.
    Zheng TL; Cen K
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4803-4809. PubMed ID: 32432743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the Tumor Suppressor Gene SPINK5 via EHMT2 Induces the Oral Squamous Cell Carcinoma Development.
    Sun S; Su G; Zheng X
    Mol Biotechnol; 2024 Feb; 66(2):208-221. PubMed ID: 37071303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of RUVBL1 in WNT/
    Zeng Y; Kong Y; Liao L; Zhu H
    Dis Markers; 2022; 2022():3398492. PubMed ID: 35493294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.
    Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
    Int J Oncol; 2019 Apr; 54(4):1183-1194. PubMed ID: 30720068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.
    Rong L; Chen B; Liu K; Liu B; He X; Liu J; Li J; He M; Zhu L; Liu K; Shi X; Shuai Y; Jin L
    J Transl Med; 2022 Apr; 20(1):148. PubMed ID: 35365168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Casticin inhibits invasion and proliferation via downregulation of β-catenin and reversion of EMT in oral squamous cell carcinoma.
    Xie Y; Zhong L; Duan D; Li T
    J Oral Pathol Med; 2019 Nov; 48(10):897-905. PubMed ID: 31318467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
    Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WDR5 promotes the tumorigenesis of oral squamous cell carcinoma via CARM1/β-catenin axis.
    Lyu XY; Shui YS; Wang L; Jiang QS; Meng LX; Zhan HY; Yang R
    Odontology; 2022 Jan; 110(1):138-147. PubMed ID: 34398317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibulin-3 sponges Tiam1 to manipulate MMP-7 activity through β-catenin signaling in oral squamous cell carcinoma.
    Guo H; Ji Y; Zhang B; Huang X
    Med Oncol; 2022 Jul; 39(10):154. PubMed ID: 35852664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SLC2A3 promotes tumor progression through lactic acid-promoted TGF-β signaling pathway in oral squamous cell carcinoma.
    Jiang W; Xu S; Li P
    PLoS One; 2024; 19(4):e0301724. PubMed ID: 38625978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FUT8-AS1/miR-944/Fused in Sarcoma/Transcription Factor 4 Feedback Loop Participates in the Development of Oral Squamous Cell Carcinoma through Activation of Wnt/β-Catenin Signaling Pathway.
    Geng Z; Huang Y; Wu S; Zhu D; Li W
    Am J Pathol; 2023 Feb; 193(2):233-245. PubMed ID: 36697118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.